A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis
Kathy Weisel, Nicola Scott, Scott Berger, Susanne Wang, Kurt Brown, Marcy Powell, Matthijs Broer, Clarissa Watts, Debra J Tompson, Susan W Burriss, Simon Hawkins, Kathy Abbott-Banner, Paul Peter Tak
BMJ Open Gastroenterology Aug 2021, 8 (1) e000680; DOI: 10.1136/bmjgast-2021-000680